GAL-001: Adaptive Phase II in Refractory Melanoma · Phase II
Mount Halifax Oncology Center · Dr. A. Reyes
consented 2026-05-13
AEs
0
Serious
0
Dropout signal
–
Adverse events
No adverse events recorded.
Data queries
No data queries.